Additional file 1: Table S3 presents the incorporation of serum biomarkers (AOPP, IL-6, and GDF15) with clinical parameters (age, gender, body mass index, SBP, FBG, and smoking) to improve the reclassification of arteriosclerosis. This evidence concerns the gene GDF15 and arteriosclerosis disorder.